Dental Caries Prevalence in Human Immunodeficiency Virus Infected Patients Receiving Highly Active Anti-Retroviral Therapy in Kermanshah, Iran

被引:0
|
作者
Rezaei-Soufi, Loghman [1 ]
Davoodi, Poorandokht [2 ]
Abdolsamadi, Hamid Reza [2 ]
Jazaeri, Mina [2 ]
Malekzadeh, Hossein [3 ]
机构
[1] Hamadan Univ Med Sci, Fac Dent, Dent Res Ctr, Dept Operat Dent, Hamadan, Iran
[2] Hamadan Univ Med Sci, Fac Dent, Dept Oral Med, Hamadan, Iran
[3] Jundishapour Univ Med Sci, Fac Dent, Dept Oral Med, Ahvaz, Iran
关键词
Dental Caries; HIV Infection; Anti-Retroviral Agents; Root Caries; Iran;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective: Introduction of new approaches for the treatment of human immunodeficiency virus (HIV) infection such as anti-retroviral medicines has resulted in an increase in the life expectancy of HIV patient. Evaluating the dental health status as a part of their general health care is needed in order to improve the quality of life in these patients. The aim of this study was to compare the root and crown caries rate in HIV patients receiving highly active antiretroviral therapy (HAART) with that rate in HIV patients without treatment option. Materials and Methods: This cross sectional study consisting of 100 individuals of both genders with human immunodeficiency virus were divided into two groups: i. group 1 (treatment group) including 50 patients with acquired immunodeficiency syndrome (AIDS) receiving HAART and ii. group 2 (control group) including 50 HIV infected patients not receiving HAART. Dental examinations were done by a dentist under suitable light using periodontal probe. For each participant, numbers of decay (D), missed (M), filled (F), Decayed missed and filled teeth (DMFT), decay surface (Ds), missed surface (Ms), filled surface (Fs), Decayed missed and filled surfaces (DMFS), and tooth and root caries were recorded. Data were analyzed using Chi-square test and independent t test using SPSS 13.0, while p-value of <0.05 was considered statistically significant in all analysis. Results: The mean and standard deviation (SD) of decayed, missed and filled teeth of those who were on highly active antiretroviral therapy was 6.86 +/- 3.57, 6.39 +/- 6.06 and 1.89 +/- 1.93, respectively. There was no significant difference between these values regarding to the treatment of patients. The mean and standard deviation of DMFT, DMFS and the number of decayed root surfaces were 15.14 +/- 6.09, 56.79 +/- 28.56, and 4.96 +/- 2.89 in patients treated by anti-retroviral medicine which were not significantly different compared to those without this treatment. Conclusion: According to the results of the present study, highly active antiretroviral therapy could not be considered as a single factor for dental caries prevalence in HIV-infected patients. However, more research is recommended to evaluate the cariogenic potential of these medicines.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 50 条
  • [1] PREVALENCE OF NEPHROLITHIASIS IN HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENTS ON THE HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY
    Raheem, Omer A.
    Mirheydar, Hossein
    Palazzi, Kerrin
    Chenoweth, Marianne
    Lakin, Charles
    Sur, Roger L.
    JOURNAL OF ENDOUROLOGY, 2012, 26 : A97 - A98
  • [2] Impaired phagocytosis among patients infected by the human immunodeficiency virus: implication for a role of highly active anti-retroviral therapy
    Michailidis, C.
    Giannopoulos, G.
    Vigklis, V.
    Armenis, K.
    Tsakris, A.
    Gargalianos, P.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2012, 167 (03): : 499 - 504
  • [3] Sebaceous gland hyperplasia, human immunodeficiency virus and highly active anti-retroviral therapy
    Short, K. A.
    Williams, A.
    Creamer, D.
    Fuller, L. C.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2008, 33 (03) : 354 - 355
  • [4] Treatment of opportunistic infections among adult and adolescent patients infected with the human immunodeficiency virus in the era of highly active anti-retroviral therapy
    Podzamczer, D
    Mallolas, J
    Peña, JM
    Pulido, F
    Aguirrebengoa, K
    Barros, C
    Blazquez, R
    Costa, JR
    Dronda, F
    Ena, J
    Guerrero, A
    Gutiérrez, F
    Juega, J
    Labarga, P
    Locutura, J
    Aldeguer, JL
    Moreno, S
    Noguerado, A
    Ocaña, I
    Padilla, B
    Pérez-Cecilia, E
    Elías, MJP
    Portilla, J
    Rivero, A
    Roca, V
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2001, 19 (08): : 376 - 392
  • [5] Bone metabolism in children with human immunodeficiency virus infection receiving highly active anti-retroviral therapy including a protease inhibitor
    Tan, BM
    Nelson, RP
    James-Yarish, M
    Emmanuel, PJ
    Schurman, SJ
    JOURNAL OF PEDIATRICS, 2001, 139 (03): : 447 - 451
  • [6] Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients:: increase during highly active anti-retroviral therapy
    Landro, L.
    Damas, J. K.
    Flo, T. H.
    Heggelund, L.
    Ueland, T.
    Tjonnfjord, G. E.
    Espevik, T.
    Aukrust, P.
    Froland, S. S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 152 (01): : 57 - 63
  • [7] Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active anti-retroviral therapy
    Sun, HY
    Chen, MY
    Hsiao, CF
    Hsieh, SM
    Hung, CC
    Chang, SC
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (04) : 381 - 388
  • [8] CLINICAL REMISSION OF HUMAN IMMUNODEFICIENCY VIRUS ASSOCIATED NEPHROPATHY RELATED TO HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY COMMENCEMENT
    Mallett, A.
    Ratanjee, S.
    Woods, M.
    NEPHROLOGY, 2011, 16 : 58 - 58
  • [9] The development of tuberculosis in patients receiving highly active anti-retroviral therapy for HIV infection
    Breen, RAM
    Smith, CJ
    Cropley, I
    Johnson, MA
    Lipman, MCI
    THORAX, 2004, 59 (01) : 37 - 37
  • [10] Improvement in Immunological Parameters in Patients Receiving Highly Active Anti-Retroviral Therapy in Nepal
    Tiwari, Bishnu Raj
    Karki, Surendra
    Ghimire, Prakash
    Sharma, Bimala
    Malla, Sarala
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2013, 66 (03) : 252 - 255